Clinical Trials Browser

Terminated × Lung Neoplasms × Hematologic Tests × Clear all

NCT01687647 2026-05-29

AMORCE-CBP

Phase 3 Terminated

Lung Neoplasms

NCT02839681 2019-05-21

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Phase 2 Terminated

2 enrolled 12 charts

Adenocarcinoma of Lung, Lung Neoplasms